Vincera Pharma Inc
(VINC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 5,533 | 9,609 | 12,059 | 15,408 | 13,040 |
| Operating Income | -5,533 | -9,609 | -12,059 | -15,408 | -13,040 |
| Other Income | 583 | 602 | 509 | 758 | 1,780 |
| Pre-tax Income | -4,950 | -9,007 | -11,550 | -14,650 | -11,260 |
| Net Income Continuous | -4,950 | -9,007 | -11,550 | -14,650 | -11,260 |
| Net Income | $-4,950 | $-9,007 | $-11,550 | $-14,650 | $-11,260 |
| EPS Basic Total Ops | -4.72 | -8.40 | -10.80 | -13.80 | -10.60 |
| EPS Basic Continuous Ops | -4.58 | -8.44 | -10.86 | -13.83 | -10.62 |
| EPS Diluted Total Ops | -4.72 | -8.40 | -10.80 | -13.80 | -10.60 |
| EPS Diluted Continuous Ops | -4.58 | -8.44 | -10.86 | -13.83 | -10.62 |
| EPS Diluted Before Non-Recurring Items | -4.60 | -9.20 | -10.40 | N/A | N/A |
| EBITDA(a) | $-5,302 | $-9,958 | $-11,473 | $-15,591 | $-13,034 |